We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9432:TSENTT Inc Analysis

Data as of 2026-03-10 - not real-time

¥154.10

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

NTT, Inc. is trading at ¥154.1, sitting just above its 20‑day SMA (¥152.5) but below the 50‑day (¥155.2) and 200‑day (¥155.5) averages, indicating a short‑term bounce within a broader bearish backdrop. The RSI of 53.5 suggests neutral momentum, while the MACD histogram is positive and the MACD signal is flagged as bullish, hinting at a potential upside toward the nearby resistance at ¥155.8. Recent earnings beat and a rising volume trend add further support to this modest upside case.
Fundamentally, the stock appears undervalued with a trailing P/E of 12.3 versus an industry average of 18.3 and an upside potential of roughly 14% based on analyst targets. A solid dividend yield of 3.44% and a payout ratio of 42% make the dividend sustainable, backed by strong operating cash flow despite negative free cash flow. However, the balance sheet is heavily leveraged (debt‑to‑equity ~281) and free cash flow remains negative, which tempers the upside. The low beta (~0.11) and extreme‑greed market sentiment (Fear‑Greed Index 80.9) further shape the risk‑return profile, positioning NTT as an attractive value play with moderate risk.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price hovering above 20‑day SMA with bullish MACD histogram
  • Increasing volume and recent earnings beat
  • Proximity to short‑term resistance at ¥155.8

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued P/E relative to industry peers
  • Stable dividend yield of 3.44% with a 42% payout ratio
  • Analyst consensus (14 analysts) recommending a buy with target price ~¥175

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strong market position in Japan's telecom sector
  • Consistent revenue growth (~5.5% YoY) and solid operating cash flow
  • Low systematic risk (beta ~0.11) and attractive dividend income

Key Metrics & Analysis

Financial Health

Revenue Growth5.50%
Profit Margin7.64%
P/E Ratio12.3
ROE10.72%
ROA2.99%
Debt/Equity281.54
P/B Ratio1.3
Op. Cash Flow¥2242.8B
Free Cash Flow¥-436653490176
Industry P/E18.3

Technical Analysis

TrendBearish
RSI53.5
Support¥150.10
Resistance¥155.80
MA 20¥152.51
MA 50¥155.25
MA 200¥155.53
MACDBullish
VolumeIncreasing
Fear & Greed Index80.89

Valuation

Fair Value¥27.14
Target Price¥176.21
Upside/Downside14.35%
GradeUndervalued
TypeBlend
Dividend Yield3.44%

Risk Assessment

Beta0.11
Volatility12.88%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.